Status:
WITHDRAWN
TMS Electrochemotherapy for Glioblastoma Multiforme
Lead Sponsor:
University of Aarhus
Conditions:
Glioblastoma
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The proposed project aims to develop novel electrochemotherapeutic treatment of glioblastoma multiforme (GBM). Standard treatment has limited effect on survival and quality of life. Electrochemotherap...
Eligibility Criteria
Inclusion
- Newly diagnosed and histologically confirmed glioblastoma multiform
- MGMT gene methylation
- If age \< 70, eligibility to comply with the Stupp radio chemotherapy regimen
- If age \> 70, eligibility for stand alone chemotherapeutic treatment
- Ability to comply with the proposed TMS treatment
- Use of validated anti-conception for fertile female participants in concordance with guidelines provided by the Danish Health and Medicines Authority
Exclusion
- Pregnancy or nursing
- Other conditions that may contraindicate the use of transcranial magnetic stimulation
- Implanted pacemaker or metal contraindicating MRI-scan
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02283944
Start Date
January 1 2015
End Date
May 31 2019
Last Update
September 20 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.